Bausch Health Companies (BHC) PT Lowered to $35 at Cowen

Go back to Bausch Health Companies (BHC) PT Lowered to $35 at Cowen

Bausch Health Announces Third-Quarter 2022 Results

November 3, 2022 7:01 AM EDT

Revenues of $2.046 billion, down 3% reported, up 2% organic basisThird quarter sales improved sequentially, notably Salix, International, and SoltaSuccessful debt exchange offer reduces debt by $2.5 billionCompany updates full year guidance

LAVAL, QC / ACCESSWIRE / November 3, 2022 / Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) ("Bausch Health" or the "Company" or "we" or "our") today announced its third-quarter 2022 financial results.

"We are encouraged with the top line... More